Founders

[spb_row element_name=”Row” wrap_type=”content-width” row_bg_type=”color” color_row_height=”content-height” bg_type=”cover” parallax_image_height=”content-height” parallax_image_movement=”fixed” parallax_image_speed=”0.5″ bg_video_loop=”yes” parallax_video_height=”window-height” parallax_video_overlay=”none” row_overlay_opacity=”0″ row_padding_vertical=”0″ row_margin_vertical=”30″ remove_element_spacing=”no” vertical_center=”true” inner_column_height=”col-natural” row_expanding=”no” row_animation=”none” row_animation_delay=”0″ minimize_row=”yes” simplified_controls=”yes” custom_css_percentage=”no” custom_css=”margin-top: 0px;margin-bottom: 0px;” border_styling_global=”default” width=”1/1″ el_position=”first last”] [spb_text_block animation=”none” animation_delay=”0″ simplified_controls=”yes” custom_css_percentage=”no” padding_vertical=”0″ padding_horizontal=”0″ margin_vertical=”0″ custom_css=”margin-top: 0px;margin-bottom: 0px;” border_size=”0″ border_styling_global=”default” width=”1/1″ el_position=”first last”]

Bengt Gustavsson

Bengt Gustavsson, MD, Ph.D, Prof. is the founder of Isofol Medical and was the head of surgical oncology at Sahlgrenska University Hospital, Gothenburg, Sweden. He co-discovered the positive effects of leucovorin on 5-FU that created the widely used combination treatment against colorectal cancer.

Bengt Gustavsson has been a member of the scientific committee of the Swedish Cancer Society since 1996, and has been a member of its scientific committee for two terms. He is a member of the American Society of Clinical Oncology, European Surgical Society, Swedish Surgical Society and the Swedish Society of Colon and Rectal Surgeons.

Yield life Science AB

Last updated 11-04-2016